168 related articles for article (PubMed ID: 6545558)
1. Treatment of Paget's bone disease with a bisphosphonate.
Fromm GA; Plantalech L; Casco C; González D; Mautalen CA
Medicina (B Aires); 1984; 44(3):245-51. PubMed ID: 6545558
[No Abstract] [Full Text] [Related]
2. Diphosphonate treatment of Paget's disease.
Finerman GA; Gonick HC; Smith RK; Mayfield JM
Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Paget's bone disease with the bisphosphonate APD.
Mautalen CA
Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
[No Abstract] [Full Text] [Related]
4. Paget's disease of bone: presentation, extent and response to bisphosphonates.
Wang LM; Au-Yeong ML; McKenna MJ
Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
[TBL] [Abstract][Full Text] [Related]
5. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Fritz P; Lioté F; Kuntz D
Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
[No Abstract] [Full Text] [Related]
6. Unusual presentation of Paget's disease of bone.
Sathyakumar S; Kapoor N; Hephzibah J; Paul TV
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944376
[No Abstract] [Full Text] [Related]
7. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
Papapoulos SE; Frölich M
J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
Ziegler R; Holz G; Minne H; Delling G
Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
[No Abstract] [Full Text] [Related]
10. [Paget's disease of the skeleton].
Ziegler R
Orthopade; 1988 Sep; 17(5):407-10. PubMed ID: 3054712
[TBL] [Abstract][Full Text] [Related]
11. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
12. Paget's disease.
Dalinka MK; Aronchick JM; Haddad JG
Orthop Clin North Am; 1983 Jan; 14(1):3-19. PubMed ID: 6219329
[No Abstract] [Full Text] [Related]
13. Strategies of treatment of Paget's disease with bisphosphonates.
Papapoulos SE
Semin Arthritis Rheum; 1994 Feb; 23(4):265-6. PubMed ID: 8009248
[No Abstract] [Full Text] [Related]
14. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
O'Doherty DP; Gertz BJ; Tindale W; Sciberras DG; Survill TT; Kanis JA
J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
[TBL] [Abstract][Full Text] [Related]
15. [Paget's disease of bone: experience with 14 cases (author's transl)].
Rojas C; Carvallo A; Valenzuela F; Aris H; Arinoviche R
Rev Med Chil; 1978 Nov; 106(11):861-8. PubMed ID: 749107
[No Abstract] [Full Text] [Related]
16. Management of Paget's Disease of the Calcaneum.
Humphrey J; Pervez A; Walker R; Abbasian A; Singh S
J Foot Ankle Surg; 2017; 56(2):401-403. PubMed ID: 28089128
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
[No Abstract] [Full Text] [Related]
18. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
[No Abstract] [Full Text] [Related]
19. Zoledronate in the treatment of Paget's disease.
Siris E
Br J Clin Pract Suppl; 1996 Sep; 87():19-20; discussion 22. PubMed ID: 8995014
[No Abstract] [Full Text] [Related]
20. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
